Correlation Between GeneReach Biotechnology and Advanced Analog

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GeneReach Biotechnology and Advanced Analog at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GeneReach Biotechnology and Advanced Analog into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GeneReach Biotechnology and Advanced Analog Technology, you can compare the effects of market volatilities on GeneReach Biotechnology and Advanced Analog and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GeneReach Biotechnology with a short position of Advanced Analog. Check out your portfolio center. Please also check ongoing floating volatility patterns of GeneReach Biotechnology and Advanced Analog.

Diversification Opportunities for GeneReach Biotechnology and Advanced Analog

0.32
  Correlation Coefficient

Weak diversification

The 3 months correlation between GeneReach and Advanced is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding GeneReach Biotechnology and Advanced Analog Technology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Advanced Analog Tech and GeneReach Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GeneReach Biotechnology are associated (or correlated) with Advanced Analog. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Advanced Analog Tech has no effect on the direction of GeneReach Biotechnology i.e., GeneReach Biotechnology and Advanced Analog go up and down completely randomly.

Pair Corralation between GeneReach Biotechnology and Advanced Analog

Assuming the 90 days trading horizon GeneReach Biotechnology is expected to under-perform the Advanced Analog. But the stock apears to be less risky and, when comparing its historical volatility, GeneReach Biotechnology is 1.38 times less risky than Advanced Analog. The stock trades about -0.09 of its potential returns per unit of risk. The Advanced Analog Technology is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest  7,290  in Advanced Analog Technology on September 13, 2024 and sell it today you would lose (430.00) from holding Advanced Analog Technology or give up 5.9% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

GeneReach Biotechnology  vs.  Advanced Analog Technology

 Performance 
       Timeline  
GeneReach Biotechnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GeneReach Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.
Advanced Analog Tech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Advanced Analog Technology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Advanced Analog is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

GeneReach Biotechnology and Advanced Analog Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GeneReach Biotechnology and Advanced Analog

The main advantage of trading using opposite GeneReach Biotechnology and Advanced Analog positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GeneReach Biotechnology position performs unexpectedly, Advanced Analog can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Advanced Analog will offset losses from the drop in Advanced Analog's long position.
The idea behind GeneReach Biotechnology and Advanced Analog Technology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Other Complementary Tools

Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device